Analysis of immature moDC generated from circulating monocytes of PP, RR, and SP MS patients revealed enhanced expression of ANKRD55 uniquely in the PP MS group, while IL6ST was decreased in all MS patients regardless of clinical course. This evidence concerns the gene IL6ST and myeloid sarcoma.